LYTIR

Insider · SEC Form 4 · Pres. Research & Development

David Young

Filed with the SEC as Young David; the order above is the one the filer's own signature uses.

In the 12 months to Nov 8, 2026, on the open market: bought $9K of PCSA. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

  1. PCSABought: Processa Pharmaceuticals, Inc. Jun 30, 2026 2,531 shares filed Jul 1, 2026 21,729 shares held directly after, as filed filing $5K
  2. PCSABought: Processa Pharmaceuticals, Inc. Jun 15, 2026 2,067 shares filed Jun 16, 2026 19,198 shares held directly after, as filed filing $5K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.